Sotalol Hydrochloride Tablet
Product Images NDC 71610-889

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 71610-889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0889 80)

Sotalol Hydrochloride 80 mg tablets label showing product name, strength, and quantity of 180 tablets. The label includes storage instructions, warnings to keep out of reach of children, NDC 71610-889-80, manufacturer Apotex Czech Industries s.r.o. in Czech Republic, and repackager Aphena Pharma Solutions - Tennessee, LLC. The label indicates prescription use only.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Figure 1 (Image 1)

A line graph depicting the relationship between Age Factor and Age in months. The Age Factor increases from approximately 0.2 at 0.1 months to 1.0 at around 24 months and beyond, illustrating an age-related scaling or adjustment factor.*

FDA Label Image

Structural Formula (Image 2)

Chemical structure diagram of Sotalol Hydrochloride depicting its molecular formula with functional groups including a sulfonamide and a hydrochloride salt.*

FDA Label Image

Figure 2 (Image 3)

A Kaplan-Meier survival curve chart comparing recurrence-free survival over 360 days among oral Sotalol hydrochloride doses of 80 mg, 120 mg, 160 mg, and placebo. The y-axis shows recurrence-free survival probability, and the x-axis represents time in days. Log-rank p-values are provided for each Sotalol dose versus placebo.*

FDA Label Image

Figure 3 (Image 4)

A survival curve chart depicting recurrence-free survival over time in days, comparing oral Sotalol hydrochloride versus placebo. The graph shows higher survival rates for the Sotalol group compared to placebo, with a p-value of 0.002 indicating statistical analysis by Log-Rank test.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.